Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
Guest Editors: Nabil F. Saba, Sue S. Yom, Missak Haigentz, and Bassel El-Rayes- Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors, Nabil F. Saba, Sue S. Yom, Missak Haigentz, and Bassel El-Rayes
Volume 2012 (2012), Article ID 291421, 2 pages - The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy, Zahi Mitri, Tina Constantine, and Ruth O'Regan
Volume 2012 (2012), Article ID 743193, 7 pages - Advances in Targeting HER3 as an Anticancer Therapy, Ning Jiang, Nabil F. Saba, and Zhuo Georgia Chen
Volume 2012 (2012), Article ID 817304, 9 pages - Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review, Amartej Merla and Sanjay Goel
Volume 2012 (2012), Article ID 387172, 11 pages - Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer, Efat Azizi, Adam Kittai, and Peter Kozuch
Volume 2012 (2012), Article ID 198197, 15 pages - The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck, Jeffery S. Russell and A. Dimitrios Colevas
Volume 2012 (2012), Article ID 761518, 13 pages - EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab, Scott A. Kono, Missak Haigentz Jr., Sue S. Yom, and Nabil Saba
Volume 2012 (2012), Article ID 901320, 10 pages - Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management, Shaad E. Abdullah, Missak Haigentz Jr., and Bilal Piperdi
Volume 2012 (2012), Article ID 351210, 10 pages - Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients, Luping Lin and Trever G. Bivona
Volume 2012 (2012), Article ID 817297, 9 pages - Deciphering the Role of Insulin-Like Growth Factor-I Receptor in Trastuzumab Resistance, Rita Nahta
Volume 2012 (2012), Article ID 648965, 7 pages